Episode 405: Buprenorphine-naloxone for pharmaceutical opioid use disorder

In episode 405, Mike and James, with yet again the very smart and helpful Tina Korownyk, go over the evidence for buprenorphine-naloxone for pharmaceutical opioid use disorder. While the evidence is at moderate to high risk of bias the results are fairly impressive with NNTs of 3-5.

Show notes

Tools for Practice

Is buprenorphine (with or without naloxone) effective as maintenance therapy in pharmaceutical opioid use disorder?